FDA Drug Application (090753) for SUMATRIPTAN; NAPROXEN SODIUM by PAR PHARM

Back to FDA Applications sponsored by PAR PHARM

Application Number090753
Product Number001
FormTABLET; ORAL
Dosage85MG; 500MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUMATRIPTAN; NAPROXEN SODIUM
Active IngredientSUMATRIPTAN; NAPROXEN SODIUM

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN SODIUM12
List of drugs with Active Ingredient SUMATRIPTAN4


Back to FDA Applications sponsored by PAR PHARM